299 related articles for article (PubMed ID: 32158192)
1. Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum Stress.
Hang L; Peng Y; Xiang R; Li X; Li Z
Drug Des Devel Ther; 2020; 14():731-744. PubMed ID: 32158192
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
[No Abstract] [Full Text] [Related]
3. Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium.
Zhao Y; Li Q; Zhao W; Li J; Sun Y; Liu K; Liu B; Zhang N
J Ethnopharmacol; 2015 Jul; 169():210-8. PubMed ID: 25922268
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-223 abrogates NLRP3 inflammasome-mediated pyroptosis to attenuate oxidized low-density lipoprotein (ox-LDL)-induced cell death in human vascular endothelial cells (ECs).
Wang X; Li X; Wu Y; Song Y
In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):670-679. PubMed ID: 32914384
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress.
Xu Y; Yuan Q; Cao S; Cui S; Xue L; Song X; Li Z; Xu R; Yuan Q; Li R
Biochem Biophys Res Commun; 2020 Sep; 529(4):998-1004. PubMed ID: 32819611
[TBL] [Abstract][Full Text] [Related]
7. Pelargonic acid vanillylamide and rosuvastatin protect against oxidized low-density lipoprotein-induced endothelial dysfunction by inhibiting the NF-κB/NLRP3 pathway and improving cell-cell junctions.
Sivasinprasasn S; Wikan N; Tocharus J; Chaichompoo W; Suksamrarn A; Tocharus C
Chem Biol Interact; 2021 Aug; 345():109572. PubMed ID: 34217687
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Effects of Simvastatin on Oxidized Low-Density Lipoprotein-Induced Endoplasmic Reticulum Stress and Apoptosis in Vascular Endothelial Cells.
Zhang GQ; Tao YK; Bai YP; Yan ST; Zhao SP
Chin Med J (Engl); 2018 Apr; 131(8):950-955. PubMed ID: 29664056
[TBL] [Abstract][Full Text] [Related]
9. NR3C2 mediates oxidised low-density lipoprotein-induced human coronary endothelial cells dysfunction via modulation of NLRP3 inflammasome activation.
Chen X; Li W; Chang C
Autoimmunity; 2023 Dec; 56(1):2189135. PubMed ID: 36919662
[TBL] [Abstract][Full Text] [Related]
10. Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells.
Song J; Li J; Hou F; Wang X; Liu B
Metabolism; 2015 Mar; 64(3):428-37. PubMed ID: 25499441
[TBL] [Abstract][Full Text] [Related]
11. ASK1 Enhances Angiotensin II-Induced Liver Fibrosis
Fang PP; Pan CW; Lin W; Li J; Huang SS; Zhou GY; Du WJ; Li Q
Mediators Inflamm; 2020; 2020():8183713. PubMed ID: 33223956
[TBL] [Abstract][Full Text] [Related]
12. Ilexgenin A inhibits endoplasmic reticulum stress and ameliorates endothelial dysfunction via suppression of TXNIP/NLRP3 inflammasome activation in an AMPK dependent manner.
Li Y; Yang J; Chen MH; Wang Q; Qin MJ; Zhang T; Chen XQ; Liu BL; Wen XD
Pharmacol Res; 2015 Sep; 99():101-15. PubMed ID: 26054569
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress-dependent activation of iNOS/NO-NF-κB signaling and NLRP3 inflammasome contributes to endothelial inflammation and apoptosis associated with microgravity.
Jiang M; Wang H; Liu Z; Lin L; Wang L; Xie M; Li D; Zhang J; Zhang R
FASEB J; 2020 Aug; 34(8):10835-10849. PubMed ID: 32592441
[TBL] [Abstract][Full Text] [Related]
14. MLKL Aggravates Ox-LDL-Induced Cell Pyroptosis via Activation of NLRP3 Inflammasome in Human Umbilical Vein Endothelial Cells.
Wu Q; He X; Wu LM; Zhang RY; Li LM; Wu CM; Lu YB; Hu B; Shi C; Lu ZF; Yang B; Zheng L; Hu YW; Wang Q
Inflammation; 2020 Dec; 43(6):2222-2231. PubMed ID: 32621119
[TBL] [Abstract][Full Text] [Related]
15. Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway.
Hong D; Bai YP; Gao HC; Wang X; Li LF; Zhang GG; Hu CP
Atherosclerosis; 2014 Aug; 235(2):310-7. PubMed ID: 24911634
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A.
Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y
Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273
[TBL] [Abstract][Full Text] [Related]
17. Acrylamide induces NLRP3 inflammasome activation via oxidative stress- and endoplasmic reticulum stress-mediated MAPK pathway in HepG2 cells.
Bo N; Yilin H; Chaoyue Y; Lu L; Yuan Y
Food Chem Toxicol; 2020 Nov; 145():111679. PubMed ID: 32805340
[TBL] [Abstract][Full Text] [Related]
18. Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells.
Wu J; Xu X; Li Y; Kou J; Huang F; Liu B; Liu K
Eur J Pharmacol; 2014 Dec; 745():59-68. PubMed ID: 25446924
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
[TBL] [Abstract][Full Text] [Related]
20. Interference with lysophosphatidic acid receptor 5 ameliorates oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury by inactivating NOD-like receptor family, pyrin domain containing 3 inflammasome signaling.
Xu L; Xu C; Lin X; Lu H; Cai Y
Bioengineered; 2021 Dec; 12(1):8089-8099. PubMed ID: 34662522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
